What 1 hospital in Kentucky charged and were paid for a Medicare hospital stay for chemotherapy with acute leukemia as secondary diagnosis or with high dose chemotherapy a (DRG 837), from 2024 Medicare claims.
Hospitals in Kentucky billed an average of $202,635 for chemotherapy with acute leukemia as secondary diagnosis or with high dose chemotherapy a, about 2.8 times the average total payment of $71,534. That payment is 13% above the U.S. average of $63,506.
These are averages for patients with original (fee-for-service) Medicare. Private insurance pays different, negotiated prices, and what you owe depends on your plan's deductible and coinsurance. Use these figures to compare hospitals, not as a quote.
About 35¢ was paid for every $1 hospitals in Kentucky billed for this stay.
Every Kentucky hospital that billed Medicare for this stay at least 11 times. Click a column to sort.
| Hospital | Stays | Avg charge | Avg payment | Medicare paid |
|---|---|---|---|---|
| University of Kentucky HospLexington | 11 | $202,635 | $71,534 | $38,408 |
In 2024 Medicare data, a hospital stay for chemotherapy with acute leukemia as secondary diagnosis or with high dose chemotherapy a (DRG 837) at 1 hospital in Kentucky was billed at $202,635 on average, while the average total payment was $71,534, of which Medicare paid $38,408. Your own cost depends on your insurance, deductible and the hospital.
Charges are a hospital's list prices. Medicare pays fixed rates set in advance, and private insurers negotiate their own discounts, so almost nobody pays the full charge. For this stay in Kentucky, average charges were 2.8 times the average payment. Uninsured patients can ask the hospital about its financial assistance (charity care) policy and cash prices.
Source: CMS, Medicare Inpatient Hospitals by Provider and Service, 2024. Average total payment includes Medicare's payment, the patient's deductible and coinsurance, and any other payer. CMS omits hospitals with fewer than 11 hospital stays for privacy. About the data.